Brief: Farmacosmo Sees 2026 EBITDA In Range €1.3-1.7 Mln
16/06/2026 09:11
BRIEF-Farmacosmo Sees 2026 EBITDA In Range €1.3-1.7 Mln June 16 (Reuters) - Farmacosmo SpA COSMO.MI:
SEES 2026 REVENUE €40-42 MILLION, EBITDA €1.3-1.7 MILLION
TARGETS 2030 REVENUE €75-77 MILLION, EBITDA €3.5-4.4 MILLION
Further company coverage: COSMO.MI
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Farmacosmo SpA
See all newsBrief: Farmacosmo Reports Fy2025 Adjusted EBITDA Of Eur 2.3 Mln
Brief: Farmacosmo Sees 2026 EBITDA In Range €1.3-1.7 Mln
Brief: Farmacosmo FY Adj EBITDA EUR 2.6 MLN
Brief: Farmacosmo Board Approves Merger By Incorporation Of Coccar S.R.L.
Brief: Farmacosmo Appoints Fabio Scognamiglio As CFO Replacing Paolo Cimmino